Literature DB >> 13236025

Pathologic changes associated with the use of sodium ethylene diamine tetra-acetate in the treatment of hypercalcemia; report of two cases with autopsy findings.

H R DUDLEY, A C RITCHIE, A SCHILLING, W H BAKER.   

Abstract

Entities:  

Keywords:  ACETIC ACID/derivatives; BLOOD; CALCIUM/in blood

Mesh:

Substances:

Year:  1955        PMID: 13236025     DOI: 10.1056/NEJM195503032520901

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Chelation therapy.

Authors:  P C Carven; H F Morrelli
Journal:  West J Med       Date:  1975-03

2.  Lead encephalopathy.

Authors:  M G ASHBY
Journal:  Proc R Soc Med       Date:  1961-03

3.  Hypercalcemia in carcinoma of the breast.

Authors:  A G JESSIMAN; K EMERSON; R C SHAH; F D MOORE
Journal:  Ann Surg       Date:  1963-03       Impact factor: 12.969

4.  Treatment of lead-poisoning with oral penicillamine.

Authors:  A GOLDBERG; J A SMITH; A C LOCHHEAD
Journal:  Br Med J       Date:  1963-05-11

5.  [Changes in rabbit skeleton in poisoning with ethylenediaminetetraacetic acid].

Authors:  W REMAGEN
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1959

6.  General medical aspects of malignant disease.

Authors:  J Q MATTHIAS
Journal:  Postgrad Med J       Date:  1961-06       Impact factor: 2.401

7.  Dermatomyositis treated with sodium ethylenediamine-tetra-acetate.

Authors:  R C POLLOCK
Journal:  Calif Med       Date:  1959-04

8.  General aspects of calcium and phosphorus metabolism with especial reference to surgical problems.

Authors:  C E DENT
Journal:  Proc R Soc Med       Date:  1956-10

9.  A review of abnormal calcium and phosphorus metabolism. I. Hypercalcaemia.

Authors:  H Z HOLLINGER; C J PATTEE
Journal:  Can Med Assoc J       Date:  1956-12-01       Impact factor: 8.262

10.  Penicillamine as lead-chelating substance in man.

Authors:  W T OHLSSON
Journal:  Br Med J       Date:  1962-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.